logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 14
  • 1
    Albers, Jeffery
    Born in July 1971
    Individual (1 offspring)
    Officer
    2023-01-01 ~ now
    OF - Director → CIF 0
  • 2
    Gladstone, Michael
    Born in October 1986
    Individual (2 offsprings)
    Officer
    2022-03-14 ~ now
    OF - Director → CIF 0
  • 3
    Blackman, Samuel
    Born in August 1968
    Individual (1 offspring)
    Officer
    2025-06-30 ~ now
    OF - Director → CIF 0
  • 4
    Chester, Cariad
    Born in July 1991
    Individual (2 offsprings)
    Officer
    2024-04-29 ~ now
    OF - Director → CIF 0
  • 5
    Damour, Bertrand
    Chief Executive Officer born in March 1957
    Individual (1 offspring)
    Officer
    2022-05-05 ~ 2023-07-10
    OF - Director → CIF 0
  • 6
    Kirkpatrick, Shaun
    Born in November 1968
    Individual (2 offsprings)
    Officer
    2015-09-18 ~ now
    OF - Director → CIF 0
  • 7
    Kariuki, Enoch
    Born in December 1981
    Individual (1 offspring)
    Officer
    2024-09-04 ~ now
    OF - Director → CIF 0
  • 8
    Thurston, David Edwin, Professor
    Professor Of Drug Discovery born in May 1955
    Individual (10 offsprings)
    Officer
    2015-07-08 ~ 2022-03-14
    OF - Director → CIF 0
  • 9
    Tobin, Jonathan Leslie
    Born in December 1982
    Individual (13 offsprings)
    Officer
    2022-03-14 ~ now
    OF - Director → CIF 0
  • 10
    Rooswinkel, Rogier Wouter, Dr
    Born in August 1983
    Individual (5 offsprings)
    Officer
    2022-03-14 ~ now
    OF - Director → CIF 0
  • 11
    Garrison, Michael Howard
    Born in February 1957
    Individual (7 offsprings)
    Officer
    2020-04-09 ~ 2022-03-14
    OF - Director → CIF 0
  • 12
    Keightley, Christopher Alan, Dr
    Company Director / Biochemist born in May 1954
    Individual (9 offsprings)
    Officer
    2015-09-18 ~ 2022-03-14
    OF - Director → CIF 0
  • 13
    Mozayeni, Cyrus
    Born in July 1974
    Individual (1 offspring)
    Officer
    2023-07-10 ~ now
    OF - Director → CIF 0
  • 14
    Brennan, Keith Gerard
    Company Director born in July 1968
    Individual (6 offsprings)
    Officer
    2015-09-18 ~ 2020-04-09
    OF - Director → CIF 0
parent relation
Company in focus

PHEON THERAPEUTICS LTD

Period: 2022-08-03 ~ now
Company number: 09677410
Registered names
PHEON THERAPEUTICS LTD - now
FEMTOGENIX LTD - 2022-08-03
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
112024-04-01 ~ 2025-03-31
92023-04-01 ~ 2024-03-31
Property, Plant & Equipment
53,716 GBP2025-03-31
960 GBP2024-03-31
Fixed Assets - Investments
5 GBP2025-03-31
Fixed Assets
53,721 GBP2025-03-31
960 GBP2024-03-31
Debtors
Current
3,990,671 GBP2025-03-31
2,311,585 GBP2024-03-31
Cash at bank and in hand
37,675,216 GBP2025-03-31
16,769,985 GBP2024-03-31
Current Assets
41,665,887 GBP2025-03-31
19,081,570 GBP2024-03-31
Creditors
Current, Amounts falling due within one year
-5,355,007 GBP2025-03-31
Net Current Assets/Liabilities
36,310,880 GBP2025-03-31
17,469,129 GBP2024-03-31
Total Assets Less Current Liabilities
36,364,601 GBP2025-03-31
17,470,089 GBP2024-03-31
Net Assets/Liabilities
36,364,601 GBP2025-03-31
17,470,089 GBP2024-03-31
Equity
Called up share capital
5,649 GBP2025-03-31
3,686 GBP2024-03-31
Share premium
104,585,187 GBP2025-03-31
56,457,832 GBP2024-03-31
Retained earnings (accumulated losses)
-68,226,235 GBP2025-03-31
-38,991,429 GBP2024-03-31
Equity
36,364,601 GBP2025-03-31
17,470,089 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
39,626 GBP2025-03-31
39,626 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
106,645 GBP2025-03-31
47,275 GBP2024-03-31
Office equipment
59,370 GBP2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
39,626 GBP2025-03-31
39,341 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
52,929 GBP2025-03-31
46,315 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment, Owned/Freehold
285 GBP2024-04-01 ~ 2025-03-31
Office equipment, Owned/Freehold
5,654 GBP2024-04-01 ~ 2025-03-31
Owned/Freehold
6,614 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Office equipment
5,654 GBP2025-03-31
Property, Plant & Equipment
Office equipment
53,716 GBP2025-03-31
Plant and equipment
285 GBP2024-03-31
Amounts Owed by Group Undertakings
Current
439,457 GBP2025-03-31
Other Debtors
Current
2,977,301 GBP2025-03-31
2,084,077 GBP2024-03-31
Prepayments/Accrued Income
Current
573,913 GBP2025-03-31
227,508 GBP2024-03-31
Trade Creditors/Trade Payables
Current
710,500 GBP2024-03-31
Amounts owed to group undertakings
Current
194,505 GBP2025-03-31
179,082 GBP2024-03-31
Taxation/Social Security Payable
Current
6,052 GBP2025-03-31
6,020 GBP2024-03-31
Other Creditors
Current
1,376 GBP2025-03-31
6,514 GBP2024-03-31
Accrued Liabilities/Deferred Income
Current
5,153,074 GBP2025-03-31
710,325 GBP2024-03-31
Creditors
Current
5,355,007 GBP2025-03-31
1,612,441 GBP2024-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
5,207,414 shares2025-03-31
5,188,168 shares2024-03-31
Class 2 ordinary share
3,800,000 shares2025-03-31
3,800,000 shares2024-03-31
Class 3 ordinary share
27,866,719 shares2025-03-31
27,866,719 shares2024-03-31
Class 4 ordinary share
19,607,843 shares2025-03-31

  • PHEON THERAPEUTICS LTD
    Info
    FEMTOGENIX LTD - 2022-08-03
    Registered number 09677410
    Innovation House Innovation Way, Discovery Park, Sandwich, Kent CT13 9FF
    PRIVATE LIMITED COMPANY incorporated on 2015-07-08 (10 years 9 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-10-19
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 5 April 2026 and licensed under the Open Government Licence v3.0.